Long-term bumetanide treatment of renal edema. Comparison with furosemide

A. Whelton

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


In an open, parallel, randomized study, bumetanide was compared with furosemide in the long-term management of patients with severe renal edema. The doses used were: bumetanide, 1 mg; furosemide, 40 mg. Graded increases were administered to daily maxima of 10 mg bumetanide and 400 mg furosemide. The efficacy of parameters measured were: weight, recumbent and standing pulse and blood pressure, abdominal girth, and estimated degree of malaise or fatigue when present. Safety parameters included: physical examination, CBC and platelets, blood chemistry, chemical and microscopic urinalysis, creatinine clearance, air audiometry, and ophthalmic examination. Weight loss and reduction of edema and of mean arterial pressure occurred in both groups of patients. In the bumetanide-treated group, weight loss was statistically significant at most observation times during the first eight weeks, and reduction in edema was significant throughout the trial (P

Original languageEnglish (US)
Pages (from-to)591-598
Number of pages8
JournalJournal of Clinical Pharmacology
Issue number11-12 II
StatePublished - 1981

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Long-term bumetanide treatment of renal edema. Comparison with furosemide'. Together they form a unique fingerprint.

Cite this